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Changes in arginase activity and AST enzyme levels in the cardiac and
skeletal muscle and liver of lambs with white muscle disease
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Abstract: The aim of this study was to evaluate arginase activity and aspartate aminotransferase (AST) levels in the tissues of the
cardiac and skeletal muscle and liver of lambs with white muscle disease (WMD). The cardiac and skeletal muscle and liver tissues were
obtained from 8 lambs with WMD and 9 apparently healthy lambs. The diagnosis of WMD was made with the detection of hyaline
degeneration upon histopathological examination. A significant increase in arginase activity in the cardiac and skeletal muscle and liver
tissues and a significant decrease in AST levels in the cardiac muscle were detected in the WMD group compared to the control group. It
was concluded that increased arginase activity in cardiac and skeletal muscle and liver may enhance polyamine synthesis for the repair
of cardiac and skeletal muscle injuries in lambs with WMD and that AST in the cardiac muscle might decrease due to the cardiac muscle
injury.
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1. Introduction
Nutritional myodegeneration, or white muscle disease
(WMD), derived from a dietary deficiency of selenium
and/or vitamin E, is characterized by cardiac and skeletal
muscle degeneration with peracute to subacute form
(1,2). The disease occurs during the first year of life,
frequently before the age of 6 months (3). In the cardiac
form, lambs with WMD show debilitation, weakness,
a short clinical course, and an agonizing death, and
in the skeletal form they often have cardiomyopathy
and stiffness due to muscular fibrosis in the limbs (1).
Significantly elevated serum aspartate aminotransferase
(AST), creatinine kinase (CK), and lactate dehydrogenase
(LDH) activities are determined during the acute phase
of myodegeneration (1,4). White patches appear in the
affected muscles (5,6), which resemble fish flesh (7). In
addition, hyaline degeneration, necrosis, and calcification
occur in myocardial and skeletal muscles (5,8).
Arginine plays a role in the regulation of muscle health
by acting on protein synthesis, inhibition of proteolysis,
and intracellular protein turnover (9). In addition,
arginine functions as a precursor to nitric oxide (NO),
polyamines, proline, glutamate, creatinine, and agmatine
* Correspondence: fbhanedan@gmail.com

(10). The metabolism products of arginine, such as nitric
oxide, citrulline, ornithine, and urea, are physiologically
important with regard to tissue injury and repair, because
the metabolite of NO can enhance tissue injury while the
ornithine metabolite of arginine by arginase can increase
tissue repair (11).
The role of arginase activity in tissue repair has not been
investigated in WMD as a nutritional myodegenerative
disease. Myodegenerative diseases may affect the muscle
AST enzyme activity. Thus, this study evaluated the
arginase activity and AST enzyme levels in tissues of
cardiac and skeletal muscle and liver in WMD in lambs.
2. Materials and methods
2.1. Animal material
Eight lambs in agony, 2–3 months old, were presented to the
Elazığ Veterinary Control Research Institute. The owner
of the lambs stated that they presented signs of weakness
and were unable to stand. The study material consisted
of the cardiac and skeletal muscle and liver tissues of the
dead lambs with WMD (WMD group) and the apparently
healthy lambs of 3.5 months (control group) supplied from
the Elkas slaughterhouse in Elazığ.
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2.2. Histopathological examination
A sample of cardiac tissue was fixed in 10% buffered
formalin solution, subjected to routine processing,
embedded in paraffin, cut into 5-µm thick sections, and
stained with hematoxylin and eosin (HE). These sections
were examined under light microscopy.
2.3. Enzyme analysis
Pieces of cardiac (right ventricle) and skeletal (gluteal
muscle) muscle and liver tissues from the diseased and
healthy lambs were excised, rinsed with 0.9% saline
(0.9% NaCl), desiccated with filter paper, and kept frozen
at –20 °C until analysis. Then 1 g of tissue samples was
homogenized with distilled water (1/10, w/v) in a glass
Potter-Elvehjem homogenizer in an ice bath. The mixture
that was homogenized was centrifuged at 14,000 × g for 10
min in a cooled centrifuge. The supernatants were used as
the enzyme source.
AST activity in the supernatants was measured with
the Reitman and Frankel method (12) and 0.2 mL of the
enzyme source was added to 1 mL of α-oxoglutarateaspartate substrate solution. The mixture was kept at 37
°C for 1 h, after which 1 mL of dinitrophenylhydrazineHCl was added. This mixture was left for 20 min at room
temperature before adding 10 mL of NaOH. The absorbance
of the resultant solution was measured against a blank (0.2
mL of distilled water instead of the enzyme source) at 505
nm in a Shimadzu UV 240 spectrophotometer. One unit
of AST activity is an enzyme activity that produces 4.82 ×
10–4 µmol glutamate at 37 °C and pH 7.5 in 1 min.
Arginase activity was determined by the measurement
of urea produced with hydrolysis of L-arginine through
arginase enzyme by the thiosemicarbazide diacetyl
monoxime urea method (13). In this analysis, the enzyme
source was diluted with MnCl2 at the rate of 1:200 for liver
and 1:5 for cardiac and skeletal muscle and was used as
a new enzyme source with preincubation at 55 °C for 5
min. Tubes that contained 0.2 mL of the enzyme source,
0.4 mL of L-arginine, and 0.4 mL of carbonate buffer were
incubated at 37 °C for 10 min. The reaction was ceased
by adding 3 mL of acid reagent to the tubes after the
incubation period. Thereafter, 2 mL of color reagent was
added to the tubes, which were kept in a boiling water bath
for 10 min. The tubes were then removed from the boiling
water bath and cooled, and absorbance was recorded at
520 nm. One unit of arginase activity is an expression in
mg protein of enzyme activity producing 1 μmol of urea
from L-arginine for 1 h at 37 °C.
The measurement of protein was carried out according
to the method of Lowry et al. (14), and bovine serum
albumin was used as standard. One milliliter of alkaline
copper reagent and 1 mL of the diluted enzyme sources were
combined and incubated for 10 min at room temperature.
Then 4 mL of Folin–Ciocalteu phenol reagent was mixed
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into the tubes, and the tubes were incubated at 55 °C for 5
min. The absorbance of the samples was recorded at 650 nm.
2.4. Statistical analysis
SPSS 12.0 was used. Differences between groups were
evaluated by independent t test. Results were given as
means ± SE. P-values of less than 0.05 were considered
significant.
3. Results
Microscopic examination determined loss of striation and
formation of degeneration and necrosis, characterized
by a pink appearance, in the muscular fibers of the
subendocardium. Focal calcifications were also recognized
in some areas. In addition, infiltration of macrophages and
mononuclear cells was detected in the interstitial area
(Figures 1 and 2).
Arginase activity and AST levels in tissues of the
cardiac and skeletal muscle and liver are given in the Table.
A significant increase in arginase activity in the cardiac
(P < 0.001) and skeletal (P < 0.05) muscle and liver (P <
0.001) tissues and a significant decrease in AST levels in
the cardiac muscle (P < 0.05) were detected in the WMD
group compared to the control group.
4. Discussion
Decrease in muscle enzymes and increase in serum
enzyme activities may occur in the different muscular
dystrophies (15). Various studies have reported that serum
and/or plasma AST values increase in lambs with WMD
(16,17). In this study, a significant decrease in AST levels
in the cardiac muscle was found in the WMD group
compared to the control group. Decreased level of cardiac
enzyme AST accounts for cardiac muscular dystrophies, as
noted microscopically, with loss of striation, myofibrillar
(hyaline) degeneration, and necrosis characterized by the
appearance of pink subendocardial muscular fibers.
Arginase activity is high in the liver for converting
arginine to urea and ornithine, while in extrahepatic
cells, such as muscle cells, macrophages, and endothelial
cells, arginase activity is determined at low levels (18,19).
Consistent with these reports, in this study arginase
activity was found to be expressed at high levels in the liver
and at relatively low levels in skeletal and cardiac muscle in
the control group.
Ornithine, the biosynthetic precursor of proline and
polyamines, is produced by arginase activity in hepatic
and nonhepatic tissues (20). For example, it has been
reported that in lactating mammary glands, liver arginase
activity increases by about 25% to provide proline, which
is necessary for milk production (21); myometrial arginase
activity increases about 25-fold during pregnancy (22).
Polyamine biosynthesis by arginase activity increases
in a variety of tumors (23,24). In this study, a significant
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Figure 1. Infiltration of macrophages, mononuclear cells, and
hyaline degeneration (H) in the cardiac muscle of lambs with
WMD stained with H&E.

Figure 2. Focal calcifications (arrow) in the cardiac muscle of
lambs with WMD stained with H&E.

Table. Arginase activity and AST levels in tissues of the cardiac and skeletal muscle and liver in lambs with
WMD and in the control group.
Tissues

Groups

Arginase
(U)

AST
(U)

Cardiac muscle

Control
WMD

0.47 ± 0.10 (0.12–0.84)
3.24 ± 0.27b (2.11–4.37)

28.50 ± 1.49 (20.64–34.56)
19.13 ± 2.0a (15.08–28.8)

Skeletal muscle

Control
WMD

11.31 ± 0.98 (8.16–16.02)
22.05 ± 2.33a (11.38–28.49)

6.03 ± 0.56 (4.08–9.6)
4.56 ± 0.61 (1.88–7.24)

Liver

Control
WMD

127.25 ± 10.33 (94.33–187.5)
218.35 ± 7.32b (204.69–252.34)

9.67 ± 0.80 (6.24–12.96)
9.20 ± 0.62 (7.2–12.05)

WMD: White muscle disease; AST: aspartate aminotransferase. Values are given as means ± SE. a: P < 0.05;
: P < 0.001. Minimum and maximum values are given in parentheses.

b

increase in arginase activity in the cardiac and skeletal
muscle and liver tissues was determined in the WMD
group compared to the control group. Several studies have
reported that M2a macrophages express increased levels of
arginase converts of arginine to polyamines (25,26); it has
also been reported that arginine metabolism by arginase
activity can cause a more profibrotic environment (27). In
the degeneration of skeletal muscle, invasion of phagocytes
and regeneration rapidly occurs, and in the degeneration
of myocardial muscle, replacement fibrosis develops (28).
In this study, it was assumed that increased cardiac and
skeletal muscle and liver arginase activity can enhance
polyamine synthesis for the repair of the injuries of cardiac
and skeletal muscle in lambs with WMD.

Enhanced catabolism of arginine, usually by arginase
activity, may result in arginine deficiency, and arginine
deficiencies disrupt many cellular and organ functions
(10). Arginine used as a dietary supplement has been
reported to have beneficial effects in the event of short-term
administration to mdx mice, a genetic model of Duchenne
muscular dystrophy (29). Thus, short-term dietary
arginine supplementation may be beneficial, in addition
to selenium and vitamin E injection, in the treatment
of WMD in lambs. Future studies may be conducted in
order to evaluate the effect of short-term dietary arginine
supplementation, in addition to selenium and vitamin E
injection, on the treatment of WMD in lambs.
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